BRZV
Get informed when a big investor buys or sells
+ FollowOvervalued by 0% based on the discounted cash flow analysis.
| Market cap | $1.31 Million |
|---|---|
| Enterprise Value | $1.75 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 5.1 |
| Outstanding Shares | 187,075,045 |
| P/E Ratio | -7.78 |
|---|---|
| PEG | 14.77 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.37 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | -0.75 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Fitvia Corp. specializes in intellectual property protection through patent formulation. The company also assists diverse organizations, ranging from startups to large corporations, by developing comprehensive business strategies and pla...